8:00AM - 5:00PM | AzPA ANTICOAGULATION CERTIFICATE TRAINING PROGRAM (Separate registration and fee)
Elizabeth Pogge, PharmD, MPH, BCPS, FASCP, FAzPA; Lindsay Davis, PharmD, BCPS, BCCP, ASH-CHC, TTS, FAzPA, FCCP; Kelly Erdos, PharmD, BCACP, CACP; Elisabeth Palmer, PharmD 

8:00AM - 12:00PM | APhA’s THE PHARMACIST & PATIENT-CENTERED DIABETES CARE CERTIFICATE TRAINING PROGRAM (Separate registration and fee)
CAPT Kimberly Langley, PharmD, MBA, BCPS; Anthony Albert, PharmD, BC-ADM, BCACP

12:00PM - 1:00PM | SSRC AWARDS RECEPTION

5:30PM - 7:00PM | AZPA BOARD OF DIRECTORS MEETING
Open to all attendees

7:30PM - 8:30PM | WELCOME RECEPTION
-Open to All Attendees-

6:00AM - 5:00PM | REGISTRATION

 

7:00AM - 7:45AM | COFFEE & NETWORKING ROUNDTABLES

Health-System SIG (ASHP Affiliate) - Mary Manning

Technician SIG (Special Group)Interest - Melinda Browning

Mentor Connection Program (MCP) - Casey Orton

Education Committee – Ariane Guthrie

Legislative Affairs Committee – Danielle Gilliam

Membership Committee – Jamie Von Glahn

Marketing Committee – Valerie Richards

AzPA Fellows – Kimberly Langley

Federal Pharmacy Professionals – Reasol Chino

Student Networking – Brianne Spaeth

Community Pharmacy - Joseph Pellerito

Residency Preceptor, RPD, RC – Jacob Schwarz

Compounding – Jimmy Stevens

7:45AM - 8:00AM | WELCOME, OVERVIEW OF CONVENTION, AND CE CLAIM PROCESS
Kelly Fine, RPh, FAzPA & Dawn Gerber, PharmD, BCGP, FASCP, FAzPA 

 

8:00AM - 9:00AM | BREAKOUT SESSION 1: ANTIOBESITY MEDICINES (AOMS): PATIENT-CENTRIC BEST PRACTICES
Kelsey Leite, PharmD

Antiobesity Medicines (AOMs) shifts the focus to the art of patient care. In this segment, we explore strategies and approaches that prioritize patient well-being, ensuring a holistic and individualized experience.

Pharmacist Learning Objectives:

1. Identify patient populations for whom AOMs may be suitable.
2. Develop strategies to mitigate potential risks associated with AOMs.
3. Describe potential barriers to adherence and compliance with AOMs.

UAN#: 0100-0000-24-016-L01-P

 

8:00AM - 9:00AM | BREAKOUT SESSION 2: LIFESTYLE MEDICINE (LM) IN PHARMACY PRACTICE: WHAT IS LM ALL ABOUT AND HOW CAN PHARMACISTS BE PREPARED TO ENGAGE IN A RAPIDLY GROWING AND EFFECTIVE DISCIPLINE
Edward Stein, PharmD, MPH, DipACLM; Jane E. Stein, PharmD

Lifestyle Medicine (LM) is a quickly growing discipline focused on lifestyle interventions that evidence has shown to prevent, manage, and in many cases reverse chronic disease.  The six pillars of LM, as described by the American College of Lifestyle Medicine, are inherently interprofessional and pharmacists should be well-prepared to engage in the integration of LM interventions as part of a comprehensive therapeutic plan to help improve the health of patients. During this activity, a description of LM (as distinct from Integrative or Functional Medicine) and the evidence of its effectiveness is provided, along with an exploration of the role of Pharmacists in LM and practical methods for integrating LM education and awareness in the continuum of Pharmacy Education.

Learning Objectives for Pharmacists and Technicians:

1. Describe Lifestyle Medicine (LM) and the Six Pillars for lifestyle
2. Discuss differences between Lifestyle Medicine and Integrative and Functional Medicine and appropriate applications as a foundation for conventional health care practice.
3. Identify three major challenges or barriers to integrating Lifestyle Medicine interventions in an interprofessional practice setting.
4. Identify areas within the continuum of pharmacy education curricula (from undergraduate, to pharmacy school, to post-graduate residency training and beyond) in which to integrate Lifestyle Medicine learning to prepare pharmacists to engage in these evidence-proven health interventions.

UAN#: 0100-0000-24-017-L99-P/T

 

9:10AM - 10:10AM | BREAKOUT SESSION 1: INK & INSIGHTS: MEDICAL WRITING FOR PHARMACY PROFESSIONALS
Kathleen Fairman, PhD, MA; Elizabeth Pogge, PharmD, MPH, BCGP, BCPS, FASCP, FAzPA

Explore new horizons in medical writing. Discover the synergy between pharmacy acumen and writing skills, essential traits for effective medical writers. Uncover the opportunities within the field of medical writing where your pharmaceutical expertise converges with the art and science of medical writing.

Learning Objectives for Pharmacists and Technicians:

1. Identify topics that may be appropriate for publication.
2. Describe how to implement clinical research into the pharmacy professional's practice.
3. Summarize existing research information efficiently to maximize the value of the pharmacy professional's work.
4. Work effectively with peer reviewer comments to produce a publishable article.

UAN#: 0100-0000-24-018-L99-P/T

 

9:10AM - 10:10AM | BREAKOUT SESSION 2: HIV AND AGING: FOCUS ON CARDIOVASCULAR RISK REDUCTION
Cassandra Anderson, PharmD, MS, BCGP, CSP, AAHIVP, CAPM

Discuss the current information, trends, and issues for cardiovascular risk reduction in the aging HIV population, with particular attention on geriatric patients. Discuss the incidence of geriatric HIV patients, the risk factors for and incidence of cardiovascular disease in HIV patients of any age, current treatment approaches and their limitations, as well as areas of ongoing research and growing trends in care.

Pharmacists Learning Objectives:

1. Identify current numbers and trends for HIV infection in the geriatric population in the United States.
2. Describe how HIV contributes to cardiovascular disease risk.
3. Discuss current treatment regimens for CVD risk reduction and their safety and effectiveness profiles in people living with HIV.
4. List population-specific factors to target for CVD risk reduction in people living with HIV.

UAN#: 0100-0000-24-019-L01-P

 

10:20AM - 11:20AM | BREAKOUT SESSION 1: HEPATITIS C-YA LATER- GUIDANCE ON SCREENING AND CURATIVE TREATMENT OPTIONS FOR HEPATITIS C
Josalynn Rightnour, PharmD; Jacob Northrup, PharmD, BC-ADM, CDCES

Overview on HCV screening best practices and how simple it can be to cure patients of this disease. Review of pangenotypic treatment options including recommended lab work and situations for referral to specialist treatment.

Learning Objectives for Pharmacists:

1. Identify eligible patients for HCV Screening.
2. List appropriate lab work for initial HCV screening.
3. Summarize pangenotypic treatment options’ counseling points.

UAN#: 0100-0000-24-020-L01-P

 

10:20AM - 11:20AM | BREAKOUT SESSION 2: THE MONOCLONAL MOSAIC: NAVIGATING ALZHEIMER'S TREATMENT FRONTIERS
Andrea Callas, PharmD; Dawn Gerber, PharmD, BCGP, FASCP, FAzPA

This presentation explores the FDA approval journey of anti-amyloid-β monoclonal antibodies in the treatment of Alzheimer's Disease. Examining the mechanisms of action of these monoclonal antibody treatments and cholinesterase inhibitors provides an essential framework for comprehending their unique approaches in addressing Alzheimer's disease. Additionally, the focus on contrasting their side effect profiles offers valuable insights, enabling healthcare professionals to make informed decisions for personalized and effective patient care.

Learning Objectives for Pharmacists:

1. Discuss anti-amyloid-β monoclonal antibodies' FDA approval process history.
2. Compare anti-amyloid-β monoclonal antibodies' and cholinesterase inhibitors' mechanism of actions.
3. Contrast anti-amyloid-β monoclonal antibodies' and cholinesterase inhibitors' adverse effect profiles.

UAN#: 0100-0000-24-021-L01-P

 

10:20AM - 11:20AM | BREAKOUT SESSION 3: A HISTORICAL EXPLORATION OF VETERINARY COMPOUNDING PHARMACY REGULATION IN THE UNITED STATES
Michael Blaire, RPh

Join us for a session delving into the historical evolution of regulatory frameworks governing veterinary compounding pharmacy in the United States. This session will provide participants with a nuanced understanding of the legislative landscape and pivotal milestones that have shaped the current regulatory environment. Gain insights into the challenges and advancements that have influenced the practice of veterinary compounding pharmacy over the years.

Learning Objectives for Pharmacists and Technicians:

1. List key legislation for veterinary compounding pharmacy in the United States.
2. Identify key legislation's implications for veterinary compounding pharmacy in the United States.
3. Describe the evolution of compounding standards and guidelines specific to veterinary pharmacy practice, recognizing their impact on ensuring the safety and efficacy of compounded medications.
4. Describe case studies illustrating notable events that have influenced regulatory decisions and shaped the landscape of veterinary compounding pharmacy.

UAN: 0100-0000-24-022-L03-P/T

 

11:30AM - 12:30PM | NON-ACCREDITED SYMPOSIUM: EXPLORE THE EVIDENCE OF A GLP-1 RA IN PATIENTS WITH T2D AND ASCVD
Sponsored by Novo Nordisk

 

12:40PM - 1:40PM | BREAKOUT SESSION 1: HOW DID MY TUESDAY CHANGE? THE CRUCIAL ROLE OF ACTIVE POLITICAL INVOLVEMENT IN SAFEGUARDING YOUR PHARMACY PROFESSION
Mark Boesen, PharmD, JD, FAzPA

This presentation will delve into the critical role of political involvement and the consequences of remaining passive in advocating for our profession's interests. Attendees will be provided with a compelling overview of why they should actively engage in politics, illustrating how decisions made by elected officials directly influence the pharmacy community. From healthcare legislation to reimbursement policies, the impact of political decisions touches every aspect of pharmacy Practice.  Moreover, this session will equip attendees with practical strategies to get involved in political advocacy at various levels. Participants will learn about local, state, and national opportunities for engagement, empowering them to leverage their individual and collective strength and amplify their voice to bring about positive change.

Learning Objectives for Pharmacists & Technicians:

1. Develop effective strategies for engaging in political advocacy.
2. Define the key principles and concepts of political advocacy.
3. Apply ethical considerations in political advocacy efforts within the pharmacy profession.

UAN#: 0100-0000-24-023-L03-P/T 

 

12:40PM - 1:40PM | BREAKOUT SESSION 2: HEY SUGAR SUGAR
Samantha Zimmerman, PharmD, MLS, BS; Jacob Northrup, PharmD, BC-ADM, CDCES; Leah Rios, PharmD Candidate

Overview of ADA 2024 DM and insulin pump guideline update. Review of CGM guideline update.

Pharmacist Learning Objectives: 

1. Identify updates to the 2024 American Diabetes Association (ADA) Standards of Care in Diabetes guidelines.
2. Choose an appropriate Continuous Glucose Monitoring (CGM) device based on patient preferences.
3. Compare CGM device characteristics for various patient populations.

Technician Learning Objectives:

1. Summarize Continuous Glucose Monitoring (CGM) device and insulin pump options for patients with diabetes.
2. Identify necessary components of Continuous Glucose Monitoring (CGM) device and insulin pump dispensing.

UAN#: 0100-0000-24-024-L01-P/T 

 

12:40PM - 1:40PM | BREAKOUT SESSION 3: TRANSITION CONSIDERATIONS FOR PROVIDERS, PAYORS, AND PATIENTS IN THE EMERGENCE OF BIOSIMILARS
Alexis Smith, PharmD; Hannah Henderson, PharmD; Lillianne Do, PharmD, BS; Pilar Gaggin, PharmD, CSP, AAHIVE

Pharmacist Learning Objectives:

1. Define biologics and biosimilars.
2. Identify interchangeable adalimumab
3. Discuss the differences between each adalimumab biosimilar including indications/dosing, side effects, efficacy, and cost.
4. Describe the advantages of using an adalimumab biosimilar over the reference product.

UAN#: 0100-0000-24-025-L04-P/T

 

1:50PM - 2:50PM | BREAKOUT SESSION 1: THREATS AND OPPORTUNITIES: A COMPOUNDING PUBLIC POLICY UPDATE
Tenille Davis, PharmD, RPh, BCSCP, FACP

Pharmacist and Technician Learning Objectives:

1. Evaluate how proposed regulation that affects the practice of compounding should be assessed.
2. Describe Pharmacy Compounding's Regulatory Framework.
3. Identify some regulatory challenges that compounding pharmacists face from the state and federal level.

This session is underwritten by a grant from the Pharmacy Compounding Foundation.

UAN#: 0100-0000-24-033-L03-P/T

 

1:50PM - 2:50PM | BREAKOUT SESSION 2: DIABETES REGIMEN PERSONALIZATION AND INTRA-CLASS MEDICATION SELECTION
Anthony Albert, PharmD, BCACP, BC-ADM

Review of current guidelines, intra-class differences between agents, and personalizing a medication regimen based on these factors.

Pharmacist Learning Objectives:

1. Apply pharmacotherapy guidelines for diabetes (ADA,AACE) to a patient case.
2. Contrast agents within the same class with respect to safety, effectiveness, pharmacokinetics, and pharmacodynamics.
3. Design a diabetes medication regimen with respect to patient characteristics.

UAN#: 0100-0000-24-026-L01-P

 

1:50PM - 2:50PM | BREAKOUT SESSION 3: EMBRACING RESILIENCE: A PERSONAL JOURNEY THROUGH ADDICTION AND LIFELONG SOBRIETY IN A PROFESSIONAL SETTING
Ryan Gries, PharmD, BCPS, BC-ADM

The purpose of this CE is to inspire, educate, and enlighten the audience by sharing a deeply personal history of addiction and the transformative journey to lifelong sobriety in the context of a pharmacy career. By delving into the challenges, breakthroughs, and resilience demonstrated, attendees will gain a deeper understanding of addiction's complexities, the personal struggles and successes of a member of the Recovery community. This session aims to equip pharmacy professionals with the tools to approach addiction with empathy and compassion, fostering a more supportive and understanding environment within a professional setting.

Learning Objectives for Pharmacists & Technicians:

1. Develop a deeper understanding of the challenges faced by individuals with addiction by actively listening to the personal story of addiction and recovery shared by the pharmacy professional.
2. Identify key factors and triggers that contribute to addiction.
3. Recognize signs of potential addiction in patients in a pharmacy setting.
4. Explore strategies for providing empathetic and non-judgmental support to individuals on their journey to recovery.

UAN#: 0100-0000-24-027-L99-P/T

 

3:00PM - 4:00PM | GENERAL SESSION: PURDUE PHARMA SUPREME COURT DECISION: UNRAVELING PAST, PRESENT, AND FUTURE IMPLICATIONS IN HEALTHCARE AND JUSTICE
Mark Boesen, PharmD, JD, FAzPA

In December 2023, the US Supreme Court connected legal claims against Purdue Pharma to its owners, the Sacklers.  The court's decision, barring lawsuits against the Sacklers to safeguard Purdue's bankruptcy settlement efforts, has raised complex questions about justice and responsibility. This program will unravel the past, examine the present, and explore potential future implications of the court's decision.

Learning Objectives for Pharmacists and Technicians:

1. Describe the December 2023 Purdue Pharma Supreme Court decision.
2. Describe the historical timeline leading to the December 2023 Purdue Pharma Supreme Court decision.
3. Examine the implications of the December 2023 Purdue Pharma Supreme Court decision.

UAN#: 0100-0000-24-028-L03-P/T

 

4:10PM - 5:10PM | BREAKOUT SESSION 1: PRECEPTOR WORKSHOP: CHOOSE YOUR OWN ADVENTURE
Janet Cooley, PharmD, BCACP; Suzanne Larson, PharmD

This session will provide participants with an interactive “Choose your own adventure” session where they will encounter common precepting challenges and choose how to handle each challenge. As preceptors move through each challenge, they will consider their own choice of action as well as their colleagues’ choices. Finally, best practices, practical experience, and literature-based solutions will be shared and participants will learn from each other. In addition to learning best practices and precepting pearls, participants will experience first-hand an innovative way to keep adult-learners involved and engaged in their own learning with the “Choose your own adventure” activity.

Learning Objectives for Pharmacists:

1. Compare and contract different approaches to precepting situations (e.g. student orientation, feedback, wellness).
2. Modify approach to precepting and student concerns based on  evidence regarding precepting.
3. Recommend a plan to incorporate precepting practices back into their practice sites.

UAN#: 0100-0000-24-029-L99-P

 

4:10PM - 5:10PM | BREAKOUT SESSION 2: HELLO INSULIN, MY OLD FRIEND, CATCHING UP ON NEW FORMULATIONS WITH REAL-WORD APPLICATION
Lisa Beckett, PharmD, BCACP, CDCES, AAHIVP; Sara Shahdoost Moghadam, PharmD, BCACP, CDCES, AAHIVP

Insulin was discovered a little over 100 years ago and continues to be a cornerstone of diabetes treatment. Over the past decade, there has been a remarkable growth in insulin formulations fueled by biosimilars, alterations to improve pharmacokinetics, and higher concentration products. Interchangeable biosimilar insulins are also now being approved by the FDA. The speakers will provide a historical perspective on insulin formulations, review recent additions to the insulin treatment space, and discuss anticipated formulations such as once weekly basal insulin. There will be information on Arizona pharmacy law specific to interchangeable biosimilar products and common safety concerns that can occur with insulin treatment. The goal of the presentation is for pharmacists and pharmacy technicians to walk away feeling more knowledgeable and empowered on how to approach insulin in their practice.

Pharmacist Learning Objectives: 

1. Review the implications of new insulin products on patient care.
2. Review legal landscape around biosimilar and interchangeable biosimilars with specific applications to insulin products.
3. Describe when a new insulin product may be preferred.
4. Describe how to perform insulin dose conversions.
5. Summarize anticipated next developments in the insulin therapy landscape with a focus on once weekly insulin(s).

Technician Learning Objectives: 

1. Identify brand and generic names of new insulin products.
2. Explain Arizona state rules for substitution with interchangeable biosimilar insulin(s).
3. Discuss upcoming advances in insulin therapy such as once weekly insulin.

UAN#: 0100-0000-24-030-L01-P/T

 

4:10PM - 5:10PM | BREAKOUT SESSION 3: THE NEW PRESCRIPTION DRUG LAW; INFLATION REDUCTION ACT
Eman Kirolos, PharmD, MS, DASPL

This CMS educational outreach activity is designed to raise awareness about the new drug law; Inflation Reduction Act (IRA). The program will cover the regulatory updates outlined in the IRA provisions so that pharmacy professionals can better assist their Medicare-covered patients. The presentation will review the provisions that were already implemented in 2023 and 2024. Participants will also learn about the major changes to Part-D benefit structure re-design that will be implemented in 2025.

Pharmacist and Technician Learning Objectives:

1. Identify the major milestones of the Inflation Reduction Act implementation.
2. Differentiate Part-B and Part-D insulin and vaccine coverage.
3. Describe how the new prescription drug law helps millions of Medicare beneficiaries.
4. List valuable resources to be shared with Medicare beneficiaries.

UAN#: 0100-0000-24-031-L03-P/T

 

5:15PM - 7:00PM | EXHIBIT HALL: WELCOME RECEPTION
Support our Convention Sponsors and Exhibitors while you mingle and enjoy appetizers!

 

7:00PM - 8:00PM | FRIENDS & ALUMNI MIDWESTERN UNIVERSITY RECEPTION

 

8:00PM - 10:00PM | ENTERTAINMENT NIGHT : NAME THAT TUNE!

6:00AM - 5:00PM | REGISTRATION

7:00AM - 7:45AM | COFFEE & NETWORKING

 

8:00AM - 5:00PM | STUDENT LEADERSHIP & LEGACY TRACK*

 

7:00AM - 5:00PM | TECHNICIAN TRACK*

 

7:45AM - 8:00AM | WELCOME, OVERVIEW OF CONVENTION, AND CE CLAIM PROCESS
Kelly Fine, RPh, FAzPA & Dawn Gerber, PharmD, BCGP, FASCP, FAzPA 

 

8:00AM - 9:00AM | GENERAL SESSION: PHARMACY BOWL
Moderator: Jacob Schwarz, PharmD, MBA, BCIDP, BCCCP, BCPS, FAzPA

General pharmacy knowledge to be presented as a game show.  Can cover number of different topics below.

Pharmacist and Technician Learning Objectives:

1. Recall the brand or generic name of medications.
2. Perform pharmacy calculations needed in different practice settings.

UAN#: 0100-0000-24-032-L01-P/T

 

9:15AM - 10:15AM | BREAKOUT SESSION 1: UNMASKING IMPOSTER SYNDROME: HOW TO CONVINCE YOUR INNER FRAUD YOU'RE THE REAL DEAL!
Bianca Glab, PharmD, MC, RPh, MC; Jacob Northrup, PharmD, BC-ADM, CDCES

In the fast-paced and demanding world of healthcare, many professionals experience the pervasive and often debilitating phenomenon known as imposter syndrome. Join us for an insightful exploration of this psychological pattern as we delve into the unique challenges faced by new and seasoned practitioners alike. Through this presentation, we will explore the different types of imposter syndrome within the healthcare context, examine its impact on individuals and teams, and offer effective strategies to overcome feelings of inadequacy and self-doubt.

Learning objectives for Pharmacists & Technicians:

1. Define imposter syndrome (IS).
2. List the subtypes of imposters.
3. Discuss effective strategies to recognize imposter syndrome.
4. Discuss effective strategies to manage imposter syndrome.

UAN #:  0100-0000-24-035-L99-P/T

 

9:15AM - 10:15AM | BREAKOUT SESSION 2: GOLDEN INSIGHTS: NAVIGATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE GUIDELINES
Courtney Coombe, PharmD, CDCES; Adrienne Waibel, PharmD, CDCES

Review of past and present GOLD guidelines including: general COPD overview, COPD maintenance medications, rescue medications, inhaler pearls, managing cost barriers, vaccinations, and importance of tobacco cessation.

Pharmacists Learning Objectives:

1. List the most up to date recommendations for management of COPD per GOLD 2024 Guidelines.
2. List the most up to date recommendations for management of COPD exacerbations per GOLD 2024 Guidelines.
3. Describe the recommended vaccine schedule in COPD patients.

UAN#:  0100-0000-24-036-L01-P

 

9:15AM - 10:15AM | BREAKOUT SESSION 3: ANTIMICROBIAL STEWARDSHIP UPDATES ACROSS THE ARIZONA HEALTHCARE SPECTRUM
Tho Pham, PharmD, BCIDP; Vanthida Huang, BSPHM, PharmD, FCCP

This presentation will review both state and federal antimicrobial stewardship updates and how pharmacists across the healthcare spectrum can make effective and evidence-based stewardship interventions.

Pharmacists Learning Objectives:

1. Discuss important updates on the CDC Priority Core Elements of Hospital Antibiotic Stewardship Programs.
2. List stewardship updates from the Arizona Department of Health Services.
3. Review the CDC Core Elements of Antibiotic Stewardship for Nursing Homes.
4. Review stewardship updates from Arizona Department of Health Services.
5. Describe CDC Core Elements of Outpatient Antibiotic Stewardship, including outpatient and dental healthcare settings.

UAN#: 0100-0000-24-037-L01-P

9:15AM - 10:15AM | BREAKOUT SESSION 4: DIVERSION WITHIN THE PHARMACY: WHAT CAN I DO? 

Kristen Snair, CPhT, MSJ, Sabrina Hernandez, CPhT 

The purpose is to bring awareness and re-education to red flags that may indicate diversion within the pharmacy. What step can be taken to mitigate diversion through responsibility, accountability, and compliance. What can be done and what should be done if diversion is suspected? The final topic is the benefit of reporting, as well as the potential negative ramifications of not reporting due to potential regulator discipline or potential patient harm.

Pharmacist and Technician Learning Objectives:  

1. Identify red flags that are cause for a level of awareness for potential diversion patterns.
2. Discuss strategies that can be deployed to mitigate diversion from pharmacy staff.
3. List and create an awareness of what can and should be done if pharmacy staff diversion is suspected along with potential consequences of non-compliance.

UAN#: 0100-0000-24-048-L08-P/T

 

10:30AM - 12:00PM | BIOSTATS 101: BASIC PRINCIPLES AND EVALUATION OF STUDIES
Jacob Schwarz, PharmD, MBA, BCIDP, BCCCP, BCPS, FAzPA

General overview of biostatistics focusing on data/variable types, measures of central tendency, statistical tests, and calculating the absolute risk reduction, relative risk reduction, and number needed to treat.

Learning Objectives for Pharmacists:

1. Differentiate between types of data (nominal, ordinal, interval/ratio), measures of central tendency, and appropriate statistical tests.  
2. Interpret hypothesis testing, p values, confidence intervals, odds and risk ratios, and both statistical and clinical significance.  
3. Define the absolute risk, relative risk, number needed to treat given data from a study. 

UAN#: 0100-0000-24-034-L99-P

 

10:30AM - 12:00PM | BREAKOUT SESSION 2: TRENDS IN HORMONAL CONTRACEPTION
Erin Raney, PharmD, BCPS, BC-ADM, FCCP; Shareen El-Ibiary, PharmD, BCPS, FCCP, FAzPA

This presentation will review recent trends in hormonal contraception and the opportunities for pharmacist-directed contraception provision in Arizona.

Pharmacist Learning Objectives:

1. Compare and contrast recently approved hormonal contraceptives.
2. Choose individualized hormonal contraceptive regimens based upon a statewide standing order for pharmacists.
3. Summarize the recommendations for the new nonprescription progestin-only contraceptive.

UAN#: 0100-0000-24-038-L01-P 

 

10:30AM - 11:30AM | BREAKOUT SESSION 3: CANDIDA AURIS: THE PATHWAY OF YEAST RESISTANCE 
Scott Volker, PharmD; Vanthida Huang, BSPHM, PharmD, FCCP  

 This clinical education program will provide an overview of the current treatment for invasive Candida auris infections and comprehensive challenges involved in the management of this emerging healthcare threat. The primary goal is to provide the audience with the knowledge and tools necessary to effectively diagnose, treat, and prevent the spread of C. auris in healthcare settings by highlighting the most current research, treatment guidelines, and infection control measures.  

 Learning Objectives:  

1. Discuss the key principles in the management of C. auris infection.  
2. Identify infection prevention and control measures for C. auris transmission and outbreaks.  
3. Describe the epidemiology and transmission of C. auris as an emerging pathogen.   
4. Describe the transmission of C. auris as an emerging pathogen.  

UAN#: 0100-0000-24-039-L01-P 

 

12:15PM - 2:00PM | EXHIBIT HALL | LUNCH
 Support our Convention Sponsors and Exhibitors while you mingle and enjoy lunch.

 

2:15PM - 3:15PM | KEYNOTE GENERAL SESSION: CONNECTING TO YOUR PASSION FOR PHARMACY AFTER BURNOUT
Jerrica Dodd, PharmD

Learning Objectives for Pharmacists and Technicians:

1. List the factors contributing to burnout in the pharmacy profession.
2. Describe the impact of burnout on personal well-being and professional performance.
3. Recognize the importance of reconnecting with one's passion for pharmacy in overcoming burnout.
4. List techniques for rediscovering and reigniting passion for the pharmacy profession.
5. Create a personalized action plan for reconnecting with passion, overcoming burnout, and enhancing job satisfaction in pharmacy practice.

UAN#: 0100-0000-24-054-L04-P/T

 

3:30PM - 5:00PM | BREAKOUT SESSION 1: IMMUNIZATION UPDATE
CAPT Holly Van Lew, PharmD, BCPS, AAHIVP, Sophia Galloway, PharmD, BCACP, FAzPA 

Provide updates on immunizations and anticipated changes in vaccine indications and future recommendations. This session will include a lecture than an interactive session in the form of a case study.

Learning Objectives for Pharmacist:

1. Discuss recent updated indications and expanded age ranges for routine vaccinations, including pneumococcal, RSV, and meningococcal.
2. Apply the current recommendations for routine vaccinations.
3. Assess current immunization practices for their practice site.
4. Determine implementation strategies for expanding vaccination efforts.
5. Discuss vaccine administration best practices, including injection technique and updated injection routes for certain live vaccines.

Learning Objectives for Technicians:

1. Describe tools and resources available for immunization schedules and recommendations.
2. Utilize the 2024 Adult & Pediatric Immunization Schedules to select the correct dose and route of administration.
3. Determine ways to support increased vaccine administration.
4. Describe ways to improve workflow support vaccinations.
5. Discuss vaccine administration best practices, including injection technique and updated injection routes for certain live vaccines.

UAN#: 0100-0000-24-040-L06-P/T

 

3:30PM - 4:30PM | BREAKOUT SESSION 2: SPECIAL OLYMPICS ARIZONA INCLUSIVE HEALTH PROGRAMS
Diane Wasley ;Wasley BS (Public Health); Ashkan Rastegar, PharmD Candidate 2024, Erin Raney, PharmD, BCPS, BC-ADM, FCCP

Pharmacists are one of the most accessible health professionals and interact with a wide range of patient populations including those with intellectual and developmental disabilities (IDD). There is a general lack of education in the health professional community in regards to the possible interactions with the IDD Community. Pharmacists can be champions of health equity and fulfill the brand promise of trust amongst the IDD community.

Learning Objectives for Pharmacists & Technicians:

1. Describe the structure of the SOAZ, including its mission, goals, and key functions.
2. Identify opportunities for pharmacy professionals within the SOAZ.
3. Discuss the practical applications of pharmacy professionals' experiences and perspectives within the context of the SOAZ.

UAN#: 0100-0000-24-041-L99-P/T

 

3:30PM - 4:30PM | BREAKOUT SESSION 3: TO EXTEND OR NOT TO EXTEND: PROLONGED INFUSION BETA-LACTAMS
Kaylee Whitenack, PharmD; Jacob Schwarz, PharmD, MBA, BCIDP, BCCCP, BCPS, FAzPA

This presentation is designed to educate pharmacy personnel on the data behind extended infusion beta lactams. There are conflicting data regarding the appropriateness and necessity of when to employ an extended infusion; thus this presentation helps to provide data to apply pharmacokinetic principles to infusion strategies on real-world patients.

Pharmacist Learning Objectives:

1. Summarize the current state of practice regarding extended-infusion beta.
2. Evaluate the evidence supporting the use of extended-infusion beta.
3. Identify the appropriate clinical scenarios to employ an extended infusion.

UAN#: 0100-0000-24-042-L01-P 

 

5:00PM - 5:45PM | PAST PRESIDENT'S RECEPTION
-Invitation Only-

7:00PM - 9:00PM | 2024 ANNUAL AWARDS PRESENTATION
Join us for a celebration of AzPA’s prestigious 2024 awardees. This evening is a not-to-be-missed event!

6:00AM - 1:00PM | REGISTRATION

7:00AM - 8:00AM | NON-ACCREDITED SYMPOSIUM - BREAKFAST

7:00AM - 7:50AM | HEADING TOWARDS OUR FUTURE: AZPA TOWN HALL
Jacob Schwarz, PharmD, MBA, BCIDP, BCCCP, BCPS, FAzPA; CAPT Kimberly Langley, PharmD, MBA, BCPS; Dawn Gerber, PharmD, BCGP, FASCP, FAzPA; Kelly Fine, RPh, FAzPA

Pharmacist and Technician Learning Objectives:

1. Describe the key components of the new strategic plan for AzPA.
2. Discuss the implications of the new strategic plan for AzPA and its stakeholders.
3. Discuss the practical implementation of the new strategic plan.

UAN: 0100-0000-24-044-L04-P/T

 

8:00AM - 9:00AM | BREAKOUT SESSION 1: THE PHARMACIST'S ROLE IN MANAGING ANXIETY, INSOMNIA, AND DEPRESSION IN OLDER ADULTS
Martha Fankhauser, BS (Pharmacy), MS (Pharmacy), BCPP, FASHP, FAzPA

This session will review the potential causes and risk factors for anxiety, insomnia, and depression in older adults. Physical health, social isolation, loneliness, loss of loved ones, and barriers to access healthcare contribute to common mental health disorders. Co-morbid disorders such as anxiety, insomnia, and depressive symptoms are also linked with substance use and suicidal behaviors. Screening for anxiety disorders, depression, and suicidal risk helps to identify patients who would benefit from counseling, interventions, and referral to providers who are trained about mental disorders. Pharmacists are important in assessing risk factors and recommending interventions to improve the quality of life for older adults. Lifestyle changes, education about nonpharmacologic and pharmacologic treatment options, and encouraging patients to take an active role in their health will help to manage common mental health conditions and improve their overall well-being.

Learning Objectives for Pharmacists:

1. Identify risk factors for mental health conditions in later life.
2. Describe treatment options for anxiety, insomnia, and depression in older adults.
3. List prevention strategies for older adults that focus on healthy aging.
4. Recommend how clinicians can recognize, assess, treat, and monitor mental health disorders in older adults.

UAN#: 0100-0000-24-045-L01-P

 

8:00AM - 9:00AM | BREAKOUT SESSION 2: VALUE BASED CARE: WHAT PROVIDERS WISH PHARMACISTS KNEW 
Cassandra Richardson, PharmD, BCACP, TTS; Adam S. Chesler, PharmD, MBA   

Learning Objectives for Pharmacists and Technicians: 

1. Describe a brief history of Medicare and value-based care (VBC).
2. Define of VBC terminology.
3. List real-life examples of VBC.
4. Explain the measures and metrics used to evaluate physicians/advanced practice practitioners (APPs).
5. Explain the areas of overlap between pharmacists and physicians/Advanced Practice Providers (APPs) concerning Healthcare Effectiveness Data and Information Set (HEDIS), Star Ratings (STAR), Consumer Assessment of Healthcare Providers and Systems (CAHPS), and various other Value-Based Care (VBC) measurement metrics.

UAN#: 0100-0000-24-047-L04-P/T

 

9:10AM - 10:10AM | BREAKOUT SESSION 1: NAVIGATING GENERATIVE AI: RISKS, BENEFITS, AND PRACTICAL APPLICATIONS
Ryan Gries, PharmD, BCPS, BC-ADM; Dawn Gerber, PharmD, BCGP, FASCP, FAzPA

Participants will gain an introductory understanding of its capabilities, exploring diverse content forms through examples such as ChatGPT, DALL-E, and Bard. The program delves into the nuanced limitations and potential pitfalls of generative AI models.  Attendees will acquire knowledge to interact effectively with generative AI and gain practical strategies for optimizing the use of generative AI will be discussed including clear prompts, thoughtful review of suggestions, and incorporation of one's unique voice during the editing process.

Learning Objectives for Pharmacists and Technicians:

1. List the types of generative artificial intelligence.
2. Articulate the potential uses of generative artificial intelligence.
3. Discuss the limitations of generative artificial intelligence.
4. Describe strategies for optimizing the use of generative.

UAN#: 0100-0000-24-046-L04-P/T

 

9:10AM - 10:10AM | BREAKOUT SESSION 2: MENTORSHIP AND SPONSORSHIP- A PANEL PERSPECTIVE

Brought to you by the AzPA MCP Committee
Casey Orton, PharmD, MBA; Yousef Toma, PharmD, BCPS, CSP, AAHIVP; Scott Barlow, CPhT; Reem Al Qazzaz, PharmD, CSP ; Jacinta Hines, PharmD

Practical discussion designed to highlight the difference between and importance of mentorship and sponsorship. Diverse panelists will delve into personal experiences to illustrate the impact mentors and sponsors have had on their professional journeys. Attendees will gain insights into becoming mentors and sponsors allowing them to support the professional development of others.

Pharmacist and Technician Learning Objectives:

1. Describe the difference between mentorship and sponsorship.
2. List the benefits of mentorship.
3. Summarize the outcomes of sponsorship.
4. Discuss methods to sponsor talent in workplace and professional network settings.

UAN#: 0100-0000-24-049-L04-P/T

 

10:20AM - 11:20AM | BREAKOUT SESSION 1: CARING BEYOND THE COUNTER: EMOTIONAL CHALLENGES IN THE OPIOID CRISIS
Jimmy Stevens, PharmD

This program explores the intricate interplay of ethics, community impact, and emotional resilience in the face of the opioid crisis. This program will discuss the ethical dilemmas confronted by the protagonist in the acclaimed Netflix movie, "The Pharmacist," offering valuable insights for pharmacy professionals. Unravel the layers of the opioid crisis and its profound effects on communities and healthcare systems, gaining a deeper understanding of the challenges at hand. Participate in meaningful discussions regarding the multifaceted issues surrounding the opioid crisis.

Pharmacist and Technician Learning Objectives:

1. Analyze the ethical dilemmas faced by the protagonist in "The Pharmacist."
2. Explore the impact of opioid crisis portrayed in "The Pharmacist" on communities and healthcare systems.
3. Discuss the emotional toll on healthcare providers dealing with societal challenges.

UAN#: 0100-0000-24-050-L08-P/T

 

10:20AM - 11:20AM | BREAKOUT SESSION 2: TAKING THE LEAP: NAVIGATING CAREER TRANSITIONS IN PHARMACY
Brought to you by the AzPA Education Committee
Ariane Guthrie, PharmD, BCGP, BCPS

This session will consist of a panel of pharmacy professionals (4-5 pharmacists/technicians) who have changed practice settings. These speakers will be prompted to speak on their experiences, challenges, and advice for other pharmacy professionals looking to make a change in their career. There will be an abbreviated slide deck (~5 min) before turning it over to the panel illustrating statistics on job satisfaction, practice settings, etc. The goal of the session is to provide resources to those AzPA members who may be interested in changing practice settings.

Learning Objectives for Pharmacists and Technicians:

1. Discuss the landscape of pharmacy and workforce projections.
2. Identify sources of job dissatisfaction and burnout among pharmacy professionals.
3. Identify resources to assist with career transitions within pharmacy.

UAN#: 0100-0000-24-051-L99-P/T

 

10:20AM - 11:20AM | BREAKOUT SESSION 3: BREAKING BARRIERS: ENHANCING PREP ACCESS AND ADHERENCE IN UNDERSERVED POPULATIONS
Yousef Toma, PharmD, BCPS, CSP, AAHIVP

Despite the proven efficacy of PrEP in preventing HIV transmission, disparities persist in its accessibility, particularly among marginalized communities. This session is essential for pharmacists seeking to bridge these gaps, equipping them with the knowledge and tools needed to address the unique challenges faced by underserved populations. The justification lies in the pressing need to dismantle barriers that hinder PrEP access, ensuring that all individuals, regardless of socio-economic status, can benefit from this crucial preventive measure. This educational session is designed to delve into the critical issues surrounding PrEP (Pre-Exposure Prophylaxis) access within underserved and under-resourced populations, exploring effective strategies to address existing barriers. Participants will gain invaluable insights into identifying vulnerable populations susceptible to HIV infection, particularly those experiencing disparities in PrEP utilization. By examining the social determinants of health and barriers to healthcare, this session aims to empower pharmacists with a comprehensive understanding of how these factors impact PrEP uptake. By identifying trends in PrEP use and persistence among different groups, attendees will be better equipped to tailor their approaches, ensuring culturally competent and effective care. The ultimate aim is to empower pharmacists with the skills and knowledge needed to champion equitable PrEP access, contributing to the broader goal of reducing HIV transmission rates and promoting health equity.

Pharmacist Learning Objectives: 

1. Identify communities at increased risk of HIV transmission who also experience disparities in accessing PrEP.
2. Describe the influence of social determinants of health and healthcare barriers on the uptake of PrEP.
3. Identify trends in PrEP use and persistence among different populations.
4. Identify effective strategies for healthcare professionals to enhance PrEP within vulnerable populations.

UAN#: 0100-0000-24-050-L08-P

 

11:30AM - 12:30PM |GENERAL SESSION:  2024 PHARMACY LAW UPDATE
Kaitlyn Fydenkevez, JD; Alex Snyder, JD, PharmD

Pharmacist & Technician Learning Objectives:

1. Describe ramifications of recent pharmacy-related court cases.
2. List recent changes in Federal Pharmacy Law.
3. List recent changes in State Pharmacy Law.

UAN: 0100-0000-24-053-L03-P/T